Novo Nordisk Lowers Some Insulin List Prices, Following Lilly’s Lead

 
• By Jessica Merrill

The company will lower the US list price of Levemir, NovoLog and certain other branded insulins by 65-75% and will also lower some unbranded insulin prices effective January 2024. Tresiba is not included.

scissors
Novo Nordisk moves on US insulin list price cuts • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas